{"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}],"units":"Participants"}],"description":"no emesis or rescue therapy administered; Delayed complete response defined as no emesis or rescue therapy required from time point of 25 hours to 120 hours following melphalan therapy administration","groups":[{"description":"aprepitant plus standard anti-emetic regimen\n\nAprepitant: Add aprepitant to anti-emetic regimen","id":"OG000","title":"Aprepitant"},{"description":"olanzapine plus standard anti-emetic regimen\n\nOlanzapine: add olanzapine to anti-emetic regimen","id":"OG001","title":"Olanzapine"},{"description":"aprepitant and olanzapine plus standard anti-emetic regimen\n\nAprepitant plus Olanzapine: add aprepitant and olanzapine to anti-emetic regimen","id":"OG002","title":"Aprepitant Plus Olanzapine"}],"populationDescription":"No data were collected or analyzed for this outcome.","reportingStatus":"POSTED","timeFrame":"25-120 hours post-transplant","title":"Delayed Complete Response","type":"SECONDARY"}